PCN445 INDIRECT TREATMENT COMPARISON OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VERSUS TISAGENLECLEUCEL (TISA-CEL) IN RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA (RR-LBCL)
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.637
https://www.valueinhealthjournal.com/article/S1098-3015(19)33015-3/fulltext
Title :
PCN445 INDIRECT TREATMENT COMPARISON OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VERSUS TISAGENLECLEUCEL (TISA-CEL) IN RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA (RR-LBCL)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33015-3&doi=10.1016/j.jval.2019.09.637
First page :
Section Title :
Open access? :
No
Section Order :
10551